← Open Payments lookup

JESSICA LUERA: Open Payments

NPI 1255811238 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$625 in 29 payments from 7 companies in 2025. Trend: 2023 $57 · 2024 $348 · 2025 $625

Food & beverage: $625
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$260
Alkermes, Inc.5$118
Janssen Pharmaceuticals, Inc4$75
Otsuka America Pharmaceutical, Inc.3$58
Teva Pharmaceuticals USA, Inc.3$48
Luye Pharma (USA) Ltd.2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28

Products named: INGREZZA, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE, CAPLYTA, VIVITROL.

Industry payments across CA — which companies pay providers there.